Original Article

Conventional and ITS1 Gene-PCR Studies on Suspected Cutaneous Leishmaniasis Patients Referred to Different Public Health Hospitals in Quetta, Pakistan

Abstract

Background: Cutaneous leishmaniasis (CL) is a neglected tropical disease that remains endemic in several areas of Balochistan Province, including Quetta city. We aimed to evaluate the effectiveness of conventional and molecular diagnostic methods for the detection and identification of CL.
Methods: Overall, 100 suspected patients were examined using conventional techniques, including microscopy, culture, and histopathology during 2024-2025, from various public hospitals of Quetta city, Pakistan. In molecular methods ITS1 gene was used to detect Leishmania on species level. Specific primers of ITS1 gene were used to amplify the targeted regions.
Results: Microscopy and PCR amplification of the ITS1 gene confirmed CL infection in 86% of cases, Culture techniques yielded promastigote growth in 16 samples, while 14 slides showed histopathological effects, indicating comparatively lower detection rates. Molecular characterization through ITS1 sequencing revealed that the isolates shared a 99% and 100% similarity with Leishmania tropica. Phylogenetic analysis further supported this relationship, confirming the predominance of this species in the study area.
Conclusion: The findings highlight the limitations of conventional diagnostic methods and focus on the implication of molecular methods, particularly PCR, for exact and early detection of CL on species-level, which is critical for effective disease management and control strategies in endemic regions like Quetta. Other demographic characteristics such as gender, age, education status, and site of lesions were also recorded.

1. Alemu, AY, Derseh, L, Kaba M, et al. Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: A systematic review and meta-analysis. PLoS One. 2023; 18(11): e0293529.
2. Rocha R, Pereira A, Maia C. Non-endemic Leishmaniases reported globally in humans between 2000 and 2021-a comprehensive review. Pathogens. 2022; 11(8): 921.
3. WHO (2023). Leishmaniasis. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis Accessed 12 January 2023.
4. Malvolti S, Malhame M, Mantel CF, et al. Human leishmaniasis vaccines: Use cases, target population and potential global demand. PLoS Negl Trop Dis. 2021; 15(9):e0009742.
5. Díaz AV, Walker M, & Webster JP. Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective. Philos Trans R Soc Lond B Biol Sci. 2023; 378(1887):20220274.
6. World Health Organization. 2022. Leishmaniasis. Fact sheets WHO.
7. Ruiz-Postigo JA, Jain S, Mikhailov A, et al. Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap. Wkly Epidemiol Rec. 2021; 96(35):401-419.
8. Rahimi BA, Ghatee MA, Habib MN, et al. Cutaneous leishmaniasis in Afghanistan. Trans R Soc Trop Med Hyg. 2025; 119(8): 848–864.
9. Borges MS, Niero LB, da Rosa LD, et al. Factors associated with the expansion of leishmaniasis in urban areas: a systematic and bibliometric review (1959-2021). J Public Health Res. 2022; 11(3): 22799036221115775.
10. Mann S, Frasca K, Scherrer S, et al. A review of leishmaniasis: current knowledge and future directions. Curr Trop Med Rep. 2021; 8(2):121–132.
11. Raffetto JD, Ligi D, Maniscalco R, et al. Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment. J Clin Med. 2020; 10(1):29.
12. Tawfeeq H M, Ali, SA. Molecular-based assay for genotyping Leishmania spp. from clinically suspected cutaneous leishmaniasis lesions in the Garmian area, Kurdistan Region of Iraq. Parasite Epidemiol Control. 2022; 17:e00240.
13. Dabirzadeh M, Rahim S, Beheshtizadeh M, et al. Species Identification and Genotyping of Cutaneous Leishmaniasis in Clinical Samples Based on ITS1-PCR-Sequencing in Southeast Iran. Iran J Public Health. 2024; 53(11):2582-2594.
14. Hakim, S, Shah W, Khan J, et al. PCR Based Detection of Cutaneous Leishmaniasis. Pak J Med Health Sci. 2023; 17(1):631-634.
15. Al-Ani SF. Detection of cutaneous Leishmaniasis based on ITS1 gene by PCR-RFLP technique. Egypt Acad J Biol Sci E Med Entomol Parasitol. 2018; 10(2):1-3.
16. Bukhari SA, Shafqat L, Bilal K, et al. Incidence of cutaneous Leishmaniasis in humans during the COVID-19 pandemic in Baluchistan Province, Pakistan. J Infect Dev Ctries. 2024; 18(6):862-869.
17. Kourieh L, Abajy MY, Alkebajy M, et al. Molecular diagnosis and epidemiological aspects of cutaneous Leishmaniasis in Aleppo: Current status. Parasite Epidemiol Control. 2025; 28:e00412.
18. Mota CA, Venazzi EA, Zanzarini PD, et al. Filter paper performance in PCR for cutaneous leishmaniasis diagnosis. Rev Soc Bras Med Trop. 2020; 54:e00472020.
19. Balahbib A, Hmamouch A, El Allam A, et al. Cutaneous leishmaniasis: physiopathology, molecular diagnostic, and therapeutic approaches. Prog Microbes Mol Biol. 2023; 6(1): https://doi.org/10.36877/pmmb.a0000395
20. Riyal H, Samaranayake N, Amarathunga P, et al. Histological findings associated with treatment response in cutaneous leishmaniasis: A clinicopathological correlation study. Int J Dermatol. 2023; 62(10):1237-47.
21. Sheikhi S, Heidari A, Mohebali M, et al. Molecular identification of cutaneous leishmaniasis species in the northcentral Iranian province of Alborz: is there a new focus on cutaneous leishmaniasis in the province? Iran J Parasitol. 2023; 18(2):244-250.
22. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4):406-425.
23. Kumar S, Stecher G, Li M, et al. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018; 35(6):1547-1549.
24. Sharifi I, Khosravi A, Aflatoonian MR, et al. Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan. Front Public Health. 2023; 11:1091709.
25. Nouroozi Kouh T, Hoghooghi Rad N, Navidpour S, et al. Molecular Identification of Cutaneous Leishmaniasis Vectors in Alborz Province, North of Iran. Arch Razi Inst. 2023; 78(4):1277-1284.
26. Ullah A, Afsheen Z, Ahmad MS, et al. Molecular Investigation of Cutaneous Leishmaniasis (CL) from Biopsy Samples: A Case Study of District Mohmand, KPK. BioSci Rev. 2024; 6(1):109-120.
27. Moghimi M, Matini M, Maghsood AH, et al. Molecular Identification of Leishmania Species in Kurdistan Province, Western Iran. Avicenna J Clin Microbiol Infect. 2025; 12(2):86-90.
28. Kayani B, Sadiq S, Rashid HB, et al. Cutaneous Leishmaniasis in Pakistan: a neglected disease needing one health strategy. BMC Infect Dis. 2021; 21(1):622.
29. Mirzapour A, Badirzadeh A, Ashrafmansouri M, et al. Super infection of cutaneous leishmaniasis caused by Leishmania major and L. tropica to Crithidia fasciculata in Shiraz, Iran. Iran J Public Health. 2019; 48(12):2285-2292.
30. Hussain M, Munir S, Khan TA, et al. Epidemiology of cutaneous leishmaniasis outbreak, Waziristan, Pakistan. Emerg Infect Dis. 2018; 24(1):159-161.
31. Flaih MH, Al-Abady FA, Hussein KR. Phylogenetic analysis of kinetoplast DNA: kDNA of Leishmania tropica in Thi-Qar province, Iraq. Comp Immunol Microbiol Infect Dis. 2021; 78:101696.
32. Wijerathna T, Gunathilaka N. Diurnal adult resting sites and breeding habitats of Phlebotomine sand flies in cutaneous leishmaniasis endemic areas of Kurunegala District, Sri Lanka. Parasit Vectors. 2020; 13(1):284.
33. Doni NY, An İ. Geriatric cutaneous leishmaniasis: a retrospective analysis of 622 cases. Postgrad Med J. 2024; 100(1187):666-670.
34. . Neamah BA, Merza FA, Saeed HM. Epidemiological and evaluative study of the prevalence of cutaneous leishmaniasis in Najaf Governorate, Iraq. Iran J Parasitol. 2026; 21(1):67-75.
35. Al Chalabi QS, Al Salman HN. Dermoscopic features in relation to the type of clinical lesions in cutaneous leishmaniasis. J Egypt Women's Dermatol Soc. 2024; 21(3):240-246.
36. Qurtas DS, Shabila N P. Using Q-methodology to understand the perspectives and practical experiences of dermatologists about treatment difficulties of cutaneous leishmaniasis. BMC Infect Dis. 2020; 20:645.
37. Ahmad S, Obaid MK, Taimur M, et al. Knowledge, attitude, and practices towards cutaneous leishmaniasis in referral cases with cutaneous lesions: A cross-sectional survey in remote districts of southern Khyber Pakhtunkhwa, Pakistan. PLoS One. 2022; 17(5):e0268801.
38. Nery RL, Santos TM, Gois LL, et al. Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review. Mem Inst Oswaldo Cruz. 2024; 119:e230240.
Files
IssueVol 21 No 3 (2026) QRcode
SectionOriginal Article(s)
Keywords
Cutaneous leishmaniasis Leishmania tropica ITS1 gene Histopathology

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mohsin AA, Naseem M, Taj I, Lashari Y, Ali K, Bibi A. Conventional and ITS1 Gene-PCR Studies on Suspected Cutaneous Leishmaniasis Patients Referred to Different Public Health Hospitals in Quetta, Pakistan. Iran J Parasitol. 2026;21(3):359-369.